Tag: IDH1

Patient Basics: Gallbladder and Bile Duct Cancer

Ivosidenib improves overall survival in IDH1-mutant advanced cholangiocarcinoma as compared to placebo

byKassandra McFarlaneand1 others

October 4, 2021

1. Patients receiving Ivosidenib had longer overall survival as compared to patients on placebo. 2. Quality of life measures favored ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Living in a marginalized neighbourhood is associated with worse outcomes in patients with myocardial infarction
SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis

No Result

View All Result